key: cord-0963889-8d4vv7x0 authors: Sepehrinezhad, Ali; Gorji, Ali; Sahab Negah, Sajad title: SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism date: 2021-07-09 journal: Inflammopharmacology DOI: 10.1007/s10787-021-00845-4 sha: 3727ee91bca2b9d45a56f5b0238b2a6c02dbd9a3 doc_id: 963889 cord_uid: 8d4vv7x0 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the central nervous system and cause several neurological manifestations. Data from cerebrospinal fluid analyses and postmortem samples have been shown that SARS-CoV-2 has neuroinvasive properties. Therefore, ongoing studies have focused on mechanisms involved in neurotropism and neural injuries of SARS-CoV-2. The inflammasome is a part of the innate immune system that is responsible for the secretion and activation of several pro-inflammatory cytokines, such as interleukin-1β, interleukin-6, and interleukin-18. Since cytokine storm has been known as a major mechanism followed by SARS-CoV-2, inflammasome may trigger an inflammatory form of lytic programmed cell death (pyroptosis) following SARS-CoV-2 infection and contribute to associated neurological complications. We reviewed and discussed the possible role of inflammasome and its consequence pyroptosis following coronavirus infections as potential mechanisms of neurotropism by SARS-CoV-2. Further studies, particularly postmortem analysis of brain samples obtained from COVID-19 patients, can shed light on the possible role of the inflammasome in neurotropism of SARS-CoV-2. Open reading frame 3a P2X7 Purinergic type 2 ATP receptor family PAMP Pathogen-associated molecular pattern PRR Pattern recognition receptor ROS Reactive oxygen species SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 TLR4 Toll-like receptor 4 TNFα Tumor necrosis factor-alpha TRAF3 Tumor necrosis factor receptor-associated factor 3 Neurological manifestations have been reported in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The neuroinvasive susceptibility of coronaviruses has been depicted in humans in previous epidemics (Hung et al., 2003; Sepehrinezhad et al., 2020) . Recently, the brain autopsy findings in a patient with SARS-CoV-2 have suggested that this virus may gain access to the CNS by infecting endothelial cells via transcytosis to neural tissue (Paniz-Mondolfi et al., 2020) . Furthermore, the post-mortem findings in patients who died from COVID-19 have revealed the presence of SARS-CoV-2 in the cortical neurons associated with minimal immune cell infiltrates in brain tissues (Song et al., 2020a) . Recently, we demonstrated the presence of SARS-CoV-2 in the cerebrospinal fluid (CSF) of patients with COVID-19 infection, who suffering from severe neurological manifestations. Despite several reports of neurological manifestations and neuroinvasiveness of SARS-CoV-2 during infection (Guan et al., 2020; Sepehrinezhad et al., 2020; Mao et al., 2020; Paniz-Mondolfi et al., 2020; Song et al., 2020b) , the determination of mechanisms underlying SARS-CoV-2-mediated neurological manifestation and brain injury are warranted. Among different mechanisms described for SARS-CoV-2, cytokine storm (i.e., releasing of the pro-inflammatory cytokines) has been suggested as the major life-threatening complication (Zhao et al., 2021) . Growing evidence has revealed that the inflammasome is activated by CoVs infections. Increasing levels of inflammasome-induced pro-inflammatory cytokines, such as interleukin-1beta (IL-1β) and interleukin 6 (IL-6), have been reported in MERS-CoV and SARS-CoV cases (He et al., 2006; Lau et al., 2013) . In SARS-CoV-2, alveolar macrophages have been speculated as the main source of inflammation (Channappanavar et al., 2016) . Immunofluorescence observations of samples from patients who died from SARS-CoV-2 infection indicated that the inflammasome pathway plays an important role in the pathogenesis of SARS-CoV-2 (Toldo et al., 2021) . Recently, it has been shown that cell death of monocytes derived from COVID-19 patients was caused by the production of IL-1B, expression of caspase-1, and cleavage of gasdermin D as the main components of the inflammasome (Ferreira et al., 2021) . Furthermore, interleukin 18 (IL-18) as other inflammasome-induced cytokines was increased in COVID-19 patients (Satış et al., 2021) . In the same way, inhibition of IL-1B displayed efficient effects on oxygenation in patients with COVID-19 pneumonia (Landi et al., 2020) . These findings suggest the involvement of inflammasomes in the pathophysiology of CoVs infections. Therefore, the aim of the present study was to review neurotropism mechanisms of SARS-CoV-2 and discuss the probable mechanisms of the inflammasome in COVID-19 patients with neurological manifestations. The three genetically described cell death pathways that have been extensively explored during the last decades are apoptosis, necroptosis, and pyroptosis. The first programmed cell death is apoptosis known as immunologically silent, which usually causes cell death through caspase-3/7-dependent manner. On the other hand, lytic cell death is caused by necroptosis and pyroptosis via the release of immunostimulatory substances. Pyroptosis in the canonical model is induced by activation of intracellular multiprotein signalling complexes known as the inflammasomes. Inflammasomes are cytosolic molecular complexes of the innate immune system that are activated in response to cellular infections and other stressors. Activation of caspase-1 and maturation of pro-inflammatory cytokines, such as IL-1β, IL-6, and IL-18 as consequences of inflammasome assembly, can restrict the intracellular pathogen replication through induction of programmed cell death (Bergsbaken et al., 2009) . Inflammasome activity usually is triggered by various sensor proteins, such as nucleotide-binding oligomerization domain-like receptor (NOD-like receptor; NLR) or AIM-2like receptor (ALR). Inflammasomes are named according to their sensor proteins, such as NLRP1, NLRP2, NLRP3, NLRP6, NLRP12, NLRC4, and AIM2 (Ting et al., 2008; Lugrin and Martinon, 2018) . The adaptor protein apoptosisassociated speck-like protein containing a caspase-recruitment domain (ASC) is associated with pro-inflammatory caspase-1 (Stehlik et al., 2003) and form the whole structure of the inflammasome complex ( Fig. 1) . Among different types of sensor proteins, NLRP3 is an important inflammasome, because it can restrict intracellular pathogen replication. The NLRP3 inflammasome is expressed by several myeloid cells, especially macrophages. The NLRP3 is activated by several stimuli including pathogen-associated molecular patterns (PAMPs), damage-associated molecular patterns (DAMPs), and viral pathogens (He et al., 2010; Toma et al., 2010; Thomas et al., 2009; Mariathasan et al., 2006) . The NLRP3 inflammasome response can be classified into activation and maintenance processes. The activation of the NLRP3 inflammasome is usually induced by ligands (i.e., PAMPs or DAMPs). These ligands bind to a pattern recognition receptor (PRR), mainly toll-like receptor-4 (TLR-4), and activate the nuclear factor kappa B (NF-κB) pathway. NF-κB increases the expression of NLRP3 protein and its proinflammatory cytokines (e.g., Pro-IL-1B and Pro-IL-18) (Bauernfeind et al., 2009 ). On one hand, the release of the lysosomal components, potassium efflux, and mitochondrial dysfunctions play important roles in the maintenance phase of NLRP3 inflammasome. In this step, the generation of reactive oxygen species (ROS), the increase of calcium concentration, and the release of mitochondrial DNA into the cytosol maintain the inflammasome complex (Guo et al., 2015) . Followed by the activated inflammasome, caspase-1 is activated and cleavages the N-terminal domain of gasdermin-D. These changes lead to a pore in the plasma membrane called pyroptosis (Chen et al., 2016) . Furthermore, activated inflammasome converts the Pro-IL-1B and Pro-IL-18 to mature forms and releases them into the extracellular space (Fig. 2) . The inflammasome is activated by CoVs infections and releases pro-inflammatory cytokines. Raising the production of pro-inflammatory cytokines is the main reason for the progression of acute respiratory distress syndrome (ARDS) and death followed by CoVs infections (Badraoui et al., 2020; Petrosillo et al., 2020) . Increasing levels of inflammasome-induced pro-inflammatory cytokines, such as IL-1β and IL-6, have been reported in MERS-CoV and SARS-CoV cases (He et al., 2006; Lau et al., 2013) . In the case of SARS-CoV-2, the source of inflammation is macrophages that are activated by PAMPs/DAMPs-derived infected pneumocytes (Channappanavar et al., 2016) . The expression of NLRP3 inflammasome and caspase-1 were significantly increased in COVID-19 patients (Toldo et al., 2021) . Viroporins are hydrophobic multifunctional proteins that play vital roles in inflammasome activation. Viroporins are encoded by viral RNA and contribute to both virus entry to the host cells and virus release from infected cells (Nieva et al., 2012) . These viroporins can form oligomeric ion channels or pores across the cell membrane. The SARS-CoV can encode several viroporins, such as the envelope (E) protein and open reading frame 3a (e.g., ORF3a, ORF8a, and ORF8b) . The E protein activates the NF-kB pathway and increases the release of calcium from the Golgi apparatus (Nieto-Torres et al., 2015) . On the other hand, ORF3a modifies ASC through a tumor necrosis factor receptor-associated factor 3 (TRAF3)-dependent (Siu et al., 2019) , while ORF8b interacts with the NLRP3 protein . Finally, by combining these interactions, NLRP3 inflammasome is activated and pyroptosis is formed by cleavage of the gasdermin-D at the linker section between the amino-terminal and carboxyl tail (Fig. 3) . During pyroptosis, sodium and water can enter the infected cells and cause cell swelling. The ORF3a accelerates the inflammasome assembly by increasing the potassium efflux and releasing ROS generation (Xu et al., 2020) . Most important, as it has been shown in recent studies, SARS-CoV-2 has several similarities in terms of phylogenetically, structurally, and pathogenicity with SARS-CoV. For instance, genomic sequence analysis tools indicated that SARS-CoV, SARS-CoV-2, and MERS belong to the cluster of beta coronaviruses Cui et al., 2019) . SARS-CoV and SARS-CoV-2 use ACE2 receptors to enter the host cells (Wan et al., 2020) . Furthermore, both of them present very similar symptoms and clinical manifestations in infected people (Gerges Harb et al., 2020; . Therefore, inflammasome-dependent pathogenicity may be seen in SARS-CoV-2. The activation of NLRP3 and its role in the pathophysiology of several neurological disorders, such as Alzheimer's disease (Halle et al., 2008; Scott et al., 2020) , Parkinson's disease Zhou et al., 2016) , multiple sclerosis (Jahanbazi Jahan-Abad et al., 2019; Malhotra et al., 2020) , and traumatic brain injury (O'Brien, 2020) have been described. Neuroinflammation is a distinguished inflammatory process in response to virus infections (i.e., neuroinvasion). It seems that SARS-CoV-2 can target and infect the BBB endothelial cells, neurons, microglia, and astrocytes (Ribeiro et al., 2021) via ACE2 and cluster of Fig. 2 Mechanisms of inflammasome assembly and pyroptosis. The inflammasome is activated by two consecutive signals. First, PAPM or DAMP initiates some pathways through PRR, mainly TLR4 that leads to an increase in the expression of NF-kβ in the nucleus. The NF-kβ triggers the production of Pro-IL-1β and Pro-IL18. The second signal is initiated by potassium efflux, lysosomal rupture, and P2X7 receptors and mitochondrial dysfunctions due to depletion of calcium reserves as well as the release of Mitochondrial DNA (MtDNA) and ROS into the cytosol. These changes create inflammasome components (i.e., NLRP3, ASC, and activated caspase-1). Activated caspase-1 cleavages the linker region of gasdermin-D and forms a pore in the cellular membrane. In addition, caspase-1 changes Pro-IL-1β and Pro-IL18 into the activated forms. Finally, these proinflammatory cytokines released into the extracellular by pores called pyroptosis. Abbreviations: ASC adaptor protein apoptosis-associated speck-like protein containing a caspase-recruitment domain; DAMP damageassociated molecular pattern; IL-1β interleukin 1beta; IL-18 inter-leukin18; mt DNA mitochondrial DNA; NF-kβ nuclear factor-kappa B; NLRP3 nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3; P2X7 purinergic type 2 ATP receptor family; PAMP pathogen-associated molecular pattern; PRR pattern recognition receptor; ROS reactive oxygen species; TLR4 tolllike receptor 4 differentiation 147 (CD147) receptors (Ribeiro et al., 2021; Chen et al., 2021) . Microglia and astrocytes are two major sources of proinflammatory cytokines and consequently neuroinflammation (Kwon and Koh, 2020) . Microglia have phagocytosis activity against infiltrating pathogens and remove neurotoxic agents. SARS-CoV-2 can directly infect brain astrocytes neurons in COVID-19 patients (Crunfli et al., 2020) . Another postmortem analysis indicated reactive astrogliosis and microglial activation in the medulla oblongata and cerebellum as well as lymphocyte infiltration in the perivascular and parenchymal area in patients who died from COVID-19 (Matschke et al., 2020) . Therefore, following SARS-CoV-2 infections, microglia and astrocytes are two main targeted cells by the virus. As studies revealed, SARS-CoV-2 can activate NLRP3 inflammasome (Xu et al., 2020; Ferreira et al., 2021; Sepehrinezhad et al., 2020; Rezaeitalab et al., 2021) . Exposure of BV-2 microglia to SARS-CoV-2 spike glycoprotein S1 increased the production of NLRP3 protein, IL-1β, IL-6, tumor necrosis factor-alpha (TNFα), and nitric oxide. In the CNS, SARS-CoV-2 enters into the glial cells, in particular microglia, through an endocytosis-dependent manner via interaction of spike proteins with ACE2 receptor. After internalization, viral RNA replicates and viral structural proteins, as well as viroporins, such as E protein, ORF3a, and ORF8b, are translated. The E proteins cause the release of calcium from the Golgi apparatus. The ORF8b interacts with NLRP3 protein. The ORF3a interacts with TRAF3 ubiquitinates ASC protein as well as increases the efflux of potassium from the cell membrane. These events along with mitochondrial dysfunctions, potassium efflux, and activated P2X7 receptors lead to activation of NLRP3 inflammasome and consequently activated caspase-1-induced pyroptosis in the glial cells. Activated proinflammatory cytokines, such as IL-1β and IL-18, trigger the production of other proinflammatory cytokines, such as TNFα, IFNβ, IL-6, and CCL2 into the CNS. IL-1β and IL-18 and other produced proinflammatory cytokines increase the permeability of the BBB and consequently enhance the infiltration of peripheral immune cells into the CNS. All these pathological processes cause severe neuroinflammation. Neuroinflammation is responsible for neuronal injury and subsequently neurological manifestations in SARS-CoV-2 infection. Abbreviations: ACE2 angiotensin-converting enzyme 2; ASC adaptor protein apoptosis-associated speck-like protein containing a caspase-recruitment domain; CD147 cluster of differentiation 147; E protein envelope protein; IL-1β interleukin 1beta; IL-18 interleukin18; mt DNA mitochondrial DNA; NLRP3 nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3; ORF3a open reading frame 3a; P2X7 purinergic type 2 ATP receptor family; ROS reactive oxygen species; TRAF3 tumor necrosis factor receptor-associated factor 3 Interestingly, SARS-CoV-2 spike glycoprotein S1 increased the activity of NF-κB and caspase-1 in BV-2 microglial cell line (Olajide et al., 2020) . Furthermore, SARS-CoV-2 spike protein triggered the production of interferon-beta (IFN-β), NF-κB, and TNFα in human microglia (Mishra and Banerjea, 2021) . Infected of both microglia and astrocyte cultures with murine coronavirus MHV-A59 increased expression of pro-inflammatory cytokines in supernatants (Lavi and Cong, 2020) . In addition, infecting mouse microglia and astrocytes with murine coronavirus MHV increased the expression of TNFα and IL-6 (Yu and Zhang, 2006) . Moreover, SARS-CoV-2 can infect human astrocytes through ACE2 and activates caspase-1 in the structure of NLRP3 inflammasome and consequently induces pyroptosis and releases of IL-1β and IL-18 into the extracellular space. Caspase-1 causes BBB disruption and initiates neuroinflammation (Israelov et al., 2020; Venero et al., 2013; Mamik et al., 2017) . In this context, IL-1β and IL-18 progress neuroinflammation and produce other proinflammatory cytokines by neuronal cells, microglia, and astrocytes (Hauptmann et al., 2020; Hewett et al., 2012; Davis et al., 2018; Arend et al., 2008) . IL-1β has also a major role in permeabilization of BBB and activation of astrocytes and microglia and consequently infiltration of peripheral immune cells into the CNS (Wang et al., 2014) . Activation of microglia and astrocytes can induce further production of cytokines and chemokines, such as TNFα, IL-6, chemokine (C-C motif) ligand 2 (CCL2), and C-X-C motif chemokine ligand 10 (CXCL10) (Thelin et al., 2018; Riazi et al., 2008; Ferrari et al., 2004) . IL-18 can also activate microglia and increase the activity of caspase-1 and the production of proinflammatory cytokines into the CNS (Felderhoff-Mueser et al., 2005; Gong et al., 2020) . On the other hand, SARS-CoV-2 viroporins and the P2X7 receptors (P2X7R) can trigger inflammasome assembly and induce pyroptosis in the infected glial cells (Campagno and Mitchell, 2021; Ribeiro et al., 2021) . As a result, inflammasome assembly forms pores in the cell membrane that causes sudden depletion of proinflammatory cytokines from infected glia into the extracellular matrix. Finally, all these pathological processes exacerbate neuroinflammation-induced neuronal injury (Kempuraj et al., 2016) and present neurological manifestations following SARS-CoV-2 infection (Fig. 3) . In this review, we suggested that inflammasome with its downstream signals can be targeted as a main pathology of SARS-CoV-2 in neurological cases. Knowledge of early signs of possible mechanisms after neurological manifestations in the course of SARS-CoV-2 is needed to be able to timely intervene with a suitable treatment. Some possible drugs are available that are previously investigated in clinical practice (Table 1) . Considerably more work will need to be done to determine the effects of these drugs on inflammasome in COVID-19 patients with neurological manifestations. In the same way, post mortem analysis is needed to clarify the exact mechanisms of inflammasome and pyroptosis in the CNS with COVID-19 infections. Corticosteroids for COVID-19 IL-1, IL-18, and IL-33 families of cytokines Efficacy of tocilizumab in COVID-19: a systematic review and meta-analysis Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID Cytokine storm in COVID-19 and parthenolide: preclinical evidence Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression Pyroptosis: host cell death and inflammation The P2X7 receptor in microglial cells modulates the endolysosomal axis, autophagy, and phagocytosis Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channelmediated necroptosis Emerging coronaviruses: Genome structure, replication, and pathogenesis The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol Origin and evolution of pathogenic coronaviruses Interleukin-1β-induced inflammatory signaling in C20 human microglial cells Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia IL-18: a key player in neuroinflammation and neurodegeneration? Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study 2020) SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review Microglia-astrocyte cross talk through IL-18/IL-18R signaling modulates migraine-like behavior in experimental models of migraine Clinical characteristics of coronavirus disease 2019 in China Inflammasomes: mechanism of action, role in disease, and therapeutics The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood-brain barrier Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome Interleukin-1β in central nervous system injury and repair Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial He Q (2020) A comparison of COVID-19 Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair Therapeutic potential of conditioned medium derived from oligodendrocytes cultured in a self-assembling peptide nanoscaffold in experimental autoimmune encephalomyelitis Efficacy of canakinumab in mild or severe COVID-19 pneumonia Neuroinflammation induces neurodegeneration Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes Blockage of interleukin-1β with canakinumab in patients with Covid-19 Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment 2020) Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling The AIM 2 inflammasome: sensor of pathogens and cellular perturbations Influence of colchicine prescription in COVID-19-related hospital admissions: a survival analysis COVID-19: Review on latest available drugs and therapies against SARS-CoV-2 Coagulation and inflammation cross-talking NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan China Cryopyrin activates the inflammasome in response to toxins and ATP Neuropathology of patients with COVID-19 in Germany: a post-mortem case series SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia Corticosteroids for COVID-19: the search for an optimum duration of therapy Parthenolide: suggested drug for COVID-19 Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome Viroporins: structure and biological functions The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target SARS-CoV-2 spike glycoprotein S1 induces neuroinflammation in BV-2 microglia Exaggerated cytokine production in human peripheral blood mononuclear cells by recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Use of mefenamic acid as a supportive treatment of COVID-19: a repurposing drug Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies COVID-19, SARS and MERS: are they closely related? Anti-inflammatory therapy for COVID-19 infection: the case for colchicine Detection of SARS-coronavirus-2 in the central nervous system of patients with severe acute respiratory syndrome and seizures Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology Divergent effects of acute versus chronic glucocorticoids in COVID-19 Tocilizumab in patients hospitalized with Covid-19 pneumonia Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19 The inflammasome adaptor protein ASC in mild cognitive impairment and Alzheimer's disease COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review Sahab-Negah S (2021) A computational-based drug repurposing method targeting SARS-CoV-2 and its neurological manifestations genes and signaling pathways Do fever-relieving medicines have anti-COVID activity: an in silico insight SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC Neuroinvasion of SARS-CoV-2 in human and mouse brain Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation Isakson BE (2020) Consideration of Pannexin 1 channels in COVID-19 pathology and treatment Elucidating pro-inflammatory cytokine responses after traumatic brain injury in a human stem cell model The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1 The NLR gene family: a standard nomenclature Inflammasome formation in the lungs of patients with fatal COVID-19 Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling Repurposing antimalaria phytomedicine artemisinin as a COVID-19 drug Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia Caspases playing in the field of neuroinflammation: old and new players Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein SARS-CoV-2 viroporin triggers the NLRP3 inflammatory pathway Differential induction of proinflammatory cytokines in primary mouse astrocytes and microglia by coronavirus infection An enlightening role for cytokine storm in coronavirus infection MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease Acknowledgements Not applicable. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.